Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

1.7K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.7K
Therapeutic Index01:13

Therapeutic Index

6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Therapeutic Communication01:30

Therapeutic Communication

7.9K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.9K
Antigen Presenting Cells01:22

Antigen Presenting Cells

3.2K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.2K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.1K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Murine autoantigen-specific type 1 regulatory T cells promote oligodendrogenesis through amphiregulin-EGFR signaling.

Science translational medicine·2026
Same author

First exposure to SARS-CoV-2 shapes IgG subclass switching after mRNA vaccination.

Communications medicine·2026
Same author

Islet-derived T cells from both mice and humans recognize conserved insulin A-chain peptides presented by HLA-C*03:04.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort.

Nature communications·2025
Same author

Correction: Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile.

Frontiers in immunology·2025
Same author

Contextual regulation of T follicular helper cell expansion and differentiation into T regulatory type 1 cells by multiple transcription factors.

Cell reports·2025

Related Experiment Video

Updated: Jan 28, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.2K

Antigen-specific therapeutic approaches for autoimmunity.

Pau Serra1, Pere Santamaria2,3

  • 1Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. pserra1@clinic.cat.

Nature Biotechnology
|February 27, 2019
PubMed
Summary

Developing antigen-based therapies to treat autoimmune diseases remains challenging. Current strategies aim to selectively reduce harmful immune responses without compromising the body's ability to fight infections.

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.4K
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

10.3K

Related Experiment Videos

Last Updated: Jan 28, 2026

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.2K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.4K
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: December 31, 2007

10.3K

Area of Science:

  • Immunology and Autoimmunity
  • Therapeutic Development

Background:

  • The immune system protects against pathogens but can mistakenly attack self-tissues, leading to autoimmune diseases.
  • Mechanisms of immune tolerance, including regulatory T and B cells, prevent self-attack.
  • While treatments for chronic inflammation exist, selective therapies for autoimmunity are lacking.

Purpose of the Study:

  • To review the evolution and current status of antigen-based strategies for treating autoimmune inflammation.
  • To assess the potential of these approaches to selectively dampen autoimmune responses.
  • To identify challenges in disease specificity, mechanism, and clinical translation.

Main Methods:

  • Review of antigen-specific therapeutic strategies for autoimmune diseases.
  • Analysis of methods delivering antigens to autoreactive T cells via antigen-presenting cells or MHC molecules.
  • Evaluation of approaches promoting clonal deletion and immunoregulation.

Main Results:

  • Autoantigen-specific therapies have evolved from simple antigen delivery to targeted strategies.
  • Approaches aim to induce tolerance by promoting deletion or regulation of autoreactive T cells.
  • Key aspects like disease specificity, underlying mechanisms, and translational potential require further clarification.

Conclusions:

  • Antigen-based strategies offer a promising avenue for selectively treating autoimmune diseases.
  • Further research is needed to clarify the mechanisms and optimize the clinical applicability of these novel therapies.
  • Developing therapies that specifically target autoimmune responses without affecting protective immunity is a critical goal.